March 23, 2010

BioCision Signs Agreement with SERVA Electrophoresis for Distribution of CoolTech Products in Europe

MILL VALLEY, Calif. -- BioCision LLC today announced that it has signed a European distribution agreement with SERVA Electrophoresis, a global supplier of reagents for scientific research. SERVA Electrophoresis will sell BioCision’s entire portfolio of CoolTech products for standardized handling and processing of temperature-sensitive biomedical and research samples.

“SERVA Electrophoresis has over 50 years of experience in providing scientists with excellent products, and we are glad to have our CoolTech portfolio included among them,” said Michelle Nemits, vice president of sales and business development for BioCision. “Expanding our distribution network through this new partnership with SERVA Electrophoresis will give researchers in Europe extended access to our products to guarantee standardized pre-analytical sample handling.”

SERVA Electrophoresis, based in Heidelberg, Germany, offers innovative and specialty products that meet the changing needs of life sciences researchers. SERVA Electrophoresis has a commitment to adapt to new challenges scientists face and to sustain consistent product quality and supply.

BioCision is the leading maker of portable benchtop tools for temperature- sensitive biomedical samples and experiments. Its highly thermo-conductive CoolRack enables easy standardization of sample cooling, snap freezing, heating and thawing. Along with CoolRacks, BioCision's portable sample coolers, freezers, and thermally conductive platforms bring portability and all-day temperature control to drug discovery, and basic and clinical research, increasing reproducibility and accuracy in scientific experiments.

BioCision products have been adopted by leading pharmaceutical and biotechnology companies, contract research organizations, and academic and healthcare institutions worldwide. BioCision’s customers include Amgen Inc., Harvard University, Genentech Inc., Novartis AG, Lawrence Livermore Laboratory, Medimmune, Merck & Co. Inc., Pfizer Inc., Stanford University, and The Systems Biology Institute, among many others.

About Biocision

BioCision LLC, the CoolTech company, designs, manufactures and markets portable benchtop tools for all temperature-sensitive biomedical samples. BioCision’s patent-pending CoolTech products enable researchers to achieve high pre-analytical sample reproducibility and consistency – experiment to experiment, lab to lab and clinical site to clinical site. The highly thermo-conductive CoolProducts, CoolRack and the complementary product lines CoolBox and CoolCell, are widely used by researchers in the pharmaceutical, biotechnology, academic and health care industries worldwide to ensure organized, protected and standardized sample handling. BioCision was founded in 2007 by a group of scientists, biomedical engineers and drug discovery experts. For more information, visit

Media Contacts:

Heidi Chokeir, Ph.D.
Russo Partners
619-528-2217 (office)
858-380-6584 (mobil)

Rolf Ehrhardt, M.D., Ph.D.


CoolCell® Controlled-rate cell freezing equivalent to CRFs

Contact BioCision:

About Us
Contact Us
Privacy Policy

© Copyright 2018, BioCision.
All rights reserved

BioCision is a life science research and development company that develops products and solutions for process standardization throughout the healthcare industry through the application of advanced thermal regulation principles and technologies. The intuitive design and interconnectivity of BioCision products enables researchers, clinicians and manufacturers to protect the integrity of temperature-sensitive therapeutics, biological samples, and biomaterials. By comprehensively addressing temperature stability, BioCision strives to improve the success of therapeutic discovery and development and enable effective care delivery.

Help 1-800-367-4887